Executive Strategic Reviews · Brazilian Healthcare Market

Why Most Foreign Healthcare Companies Quietly Fail in BrazilEven with distributors, competitive pricing, and ANVISA approval.

Because the real problem is rarely the product —
it's the structure behind the market entry.

Watch

Watch the Strategic Briefing

A concise executive overview explaining why most international healthcare companies struggle to scale in Brazil.

Executive Framework 01

Entering Brazil Is Easy.
Scaling Brazil Is Different.

Entering Brazil
Scaling Brazil
ANVISA Approval
Commercial Adoption
Distributor Appointment
Market Access
First Meetings
Sustainable Growth
Product Registration
Revenue Generation
Opportunities
Execution Capability

Most healthcare companies focus on entering Brazil.
But few focus on building a structure truly capable of scaling their business.

Executive Insight 02

Brazil Is Not Difficult.
It Is Structurally Different.

Regulation

Approval does not create demand.

Distribution

Access does not guarantee execution.

Pricing

Lower prices do not automatically create adoption.

Market Access

Relationships matter as much as products.

Structure

Growth is often determined before the first sale.

Control

Visibility drives decision quality.

The companies that succeed in Brazil usually have better connections and market structures — not necessarily better products.

Strategic Diagnostic 03

The Real Risk Isn't Lack Of Information.

It is the confidence built on incomplete signals and misleading information.

  1. 01Information
  2. 02Contacts
  3. 03Meetings
  4. 04Confidence
  5. 05Wrong Conclusions
  6. 06Costly Decisions

False Clarity

When information creates confidence before understanding exists.

The Invisible Problem 04

The Distributor Savior Illusion

01

Company

02

Distributor

03

Market

What Is Lost Along The Way

Loss of

Control

Loss of

Visibility

Loss of

Data

Loss of

Feedback

Loss of

Strategic Flexibility

What initially appears to simplify market entry often becomes the primary limitation to sustainable growth.

LINK Healthcare Method 05

Control Architecture

The five structural pillars behind every successful Brazil market entry.

01

Product Registration

02

Market Access

03

Channel Strategy

04

Positioning

05

Execution

Segmentation 06

Who We Help

Profile A

Entering Brazil

Companies evaluating market entry.

Profile B

Looking For A Distributor

Companies seeking channel partners.

Profile C

Already Selling

Companies seeking growth acceleration.

Profile D

Underperforming

Companies experiencing commercial stagnation.

Profile E

Scaling

Companies preparing for expansion.

Authority

Built On Decades Inside Brazilian Healthcare Market

25+

Years

Healthcare Market Experience

100

Most Influential

Brazilian Healthcare

Top 100

Of The Decade

Brazilian Healthcare

Global

Companies Served

International Healthcare

Ronald Lorentziadis

Ronald Lorentziadis

Founder · LINK Healthcare

Elected among the 100 Most Influential of the Decade in Brazilian Healthcare. Trusted by international healthcare companies entering and scaling in Brazil.

Connect on LinkedIn

International Healthcare Companies Served

Hartmann logo
Medline logo
Ansell logo
KCI logo
Talley logo
Altoida logo
Berchtold logo
BioSoma logo
Palmedic logo

Executive Briefing

Executive Strategic Review

A private discussion designed to help healthcare companies identify strategic blind spots, structural risks, and growth opportunities before major decisions are made.

Topics Covered

Market Entry
Distributor Strategy
Market Access
Pricing
Growth Planning
Structural Risks
Strategic Priorities
Expansion Planning

Periodic Briefings

Executive Insights & Strategic Briefings

Receive periodic perspectives on the Brazilian healthcare market.

Healthcare Market Access
Distributor Strategy
ANVISA Developments
Pricing Dynamics
Growth Lessons
Strategic Healthcare Intelligence

Request an Executive Strategic Review

Fix the structure first.
Scale your business in Brazil with clarity, control, and strategic alignment.

FAQ

Frequently Asked Questions

Executive Strategic Review

Request Review